Envoy Medical, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Envoy Medical, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q3 2024.
  • Envoy Medical, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -180 %, a 130% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -180 -102 -130% Sep 30, 2024
Q2 2024 -363 -298 -464% Jun 30, 2024
Q1 2024 -127 -52.3 -69.9% Mar 31, 2024
Q4 2023 -76 +17.4 +18.6% Dec 31, 2023
Q3 2023 -78.5 +8.01 +9.26% Sep 30, 2023
Q2 2023 -64.3 +30.1 +31.9% Jun 30, 2023
Q1 2023 -74.8 +24.1 +24.3% Mar 31, 2023
Q4 2022 -93.3 +7.79 +7.7% Dec 31, 2022
Q3 2022 -86.5 +51.7 +37.4% Sep 30, 2022
Q2 2022 -94.4 Jun 30, 2022
Q1 2022 -98.9 Mar 31, 2022
Q4 2021 -101 Dec 31, 2021
Q3 2021 -138 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.